Literatur
-
1
Attal M, Harousseau J L, Stoppa A M. et al .
High dose therapy in multiple myeloma:
Final analysis of a prospective randomized study of the „Intergroup
Francais Du Myelome” (IFM90) (Abstr.).
Blood.
1995;
86
124a
-
2
Bataille R, Harousseau J L.
Multiple
myeloma.
New Engl J Med.
1997;
336
1657-1664
-
3
Blade J, Kyle R A, Greipp P R.
Presenting
features and prognosis in 72 patients with multiple myeloma who
were younger than 40 years.
Br J Haematol.
1996;
93
345-351
-
4
Caturelli E, Squillante M M, Castelvetere M, Falcone A, Musto P.
Myelomatous nodular lesions of the liver:
diagnosis by ultrasound-guided fine-needle biopsy.
J Clin
Ultrasound.
1993;
21
133-137
-
5
Curtis J M, Pellegrini V, Tappin J A.
Case
Report: Multiple myeloma - a rare presentation.
Clin
Radiol.
1995;
50
63-64
-
6
Edwards G A, Zawadski Z A.
Extraosseous
lesions in plasma cell myeloma. A report of 6 cases.
Am
J Med.
1967;
43
194-205
-
7
Heyll A, Schneider P, Bauser U. et al .
Aktuelle Therapiekonzepte bei Patienten
mit multiplem Myelom.
Dtsch Med Wochenschr.
2000;
125
1201-1209
-
8
Kapadia S B.
Multiple
myeloma: A clinicopathologic study of 62 consecutively autopsied
cases.
Medicine.
1980;
59
380-392
-
9
Kyle R A.
Multiple
myeloma: Review of 869 cases.
Mayo Clin Proc.
1975;
50
29-40
-
10
Leo R, Boeker M, Peest D. et
al .
Multiparameter analyses of normal and malignant
human plasma cells: CD38++, CD56+, CD54+,
cIg+ is the common phenotype of myeloma cells.
Ann
Hematol.
1992;
64
132-139
-
11
Miyasaka M.
Cancer
metastasis and adhesion molecules.
Clin Orthop.
1995;
312
10-18
-
12
Moulopoulos L A, Granfield C AJ, Dimopoulos M A. et al .
Extraosseous multiple
myeloma: imaging features.
AJR.
1993;
161
1083
-
13
Oshima K, Kanda Y, Nannya Y. et al .
Clinical and pathologic findings in 52
consecutively autopsied cases with multiple myeloma.
Am
J Haematol.
2001;
67
1-5
-
14
Pellat-Deceunynck C, Barille S, Puthier D. et al .
Adhesion molecules on human myeloma cells:
significant changes in expression related to malignancy, tumor spreading,
and immortalization.
Cancer Research.
1995;
55
3647-3653
-
15
Perez-Soler R, Esteban R, Allende E. et al .
Liver involvement in multiple myeloma.
Am
J Hematol.
1985;
20
25
-
16
Pinkus G S, Said J W.
Specific identification
of intracellular immunoglobulin in parrafin sections of multiple
myeloma and macroglobulinemia using an immunoperoxidase technique.
Am
J Pathol.
1977;
87
47-55
-
17
Simmons M Z, Miller J A, Levine C D, Glucksman W J, Wachsberg R H.
Myelomatous involvement of the
liver: unusual ultrasound appearance.
J Clin Ultrasound.
1997;
25
145-148
-
18
Solves P, De la Rubia J, Jarque I. et al .
Liver disease as primary manifestation
of multiple myeloma in a young man.
Leuk Res.
1999;
23
403-405
-
19
Sucker C, Stockschläder M.
Das extramedulläre
Plasmozytom.
Dtsch Med Wochenschr.
2002;
127
153-155
-
20
Thomas F B, Clausen K P, Greenberger N J.
Liver disease in multiple myeloma.
Arch
Intern Med.
1973;
132
195-202
-
21
Walz-Mattmüller R, Horny H P, Ruck P, Kaiserling E.
Incidence
and pattern of liver involvement in haematological malignancies.
Pathol
Res Pract.
1998;
194
781-789
-
22
Yoon Y S, Min Y H, Chon C Y. et al .
Liver involvement in multiple
myeloma proven by peritoneoscopy: A case report.
Yonsei
Med J.
1993;
34
90-97
-
23
Zeromski J, Nyczak E, Dyszkiewicz W.
Significance
of cell adhesion molecules, CD56/NCAM in particular, in
human tumor growth and spreading.
Folia Histochem Cytobiol.
2001;
39
(Suppl 2)
36-37
Dr. med. Christoph Sucker
Klinik und Poliklinik für Innere Medizin C, Hämatologie
und Onkologie, Ernst-Moritz-Arndt-Universität
Sauerbruchstraße
17589 Greifswald
Phone: 0049/3834/866618
Fax: 0049/3834/867290
Email: sucker@uni-greifswald.de
